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Aging is associated chronic inflammation and autoimmunity, and increased levels of leptin. Increased levels of
leptin are associated with inflammation and autoimmunity. We have recently reported that leptin activates B cells
to induce secretion of proinflammatory and anti-inflammatory cytokines. Role of B cells and leptin in inflammation
associated with aging has not been explored. In this study we demonstrate that leptin activates and induces
significantly greater amount of IL-6, TNF-α, and IL-10 by B cells from aged humans as compared to young controls.
This is associated with increased leptin-induced phosphorylation of STAT3 (signal transducer and activator of
transcription-3) in B cells from aged humans as compared to young subjects. These data suggest that
leptin-induced B cell-derived proinflammatory cytokines may play a role in chronic inflammation associated with
human aging.
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Leptin, one of adipokines induces secretion of a number
of proinflammatory cytokines, including IL-6, IL-1, and
TNF-α [1-5]. Serum levels of leptin,TNF-α, IL-6, and
other proinflammatory cytokines are increased during
human aging and age-associated inflammatory disorders
[6-15]. However, the cellular source of these cytokines in
aging is poorly understood. These cytokines are pro-
duced by T cells, macrophages, and B cells. However, T
cell-derived and macrophage-derived proinflammatory
cytokines are decreased in aging [16-20]. Therefore, B
cells are likely the source of increased proinflammatory
cytokines in aging. B cell derived inflammatory cytokines
have not been studied in aging. During aging adipose tis-
sue is increased in the lymph nodes and the bone mar-
row, which may result in leptin levels that may be 10 to
100 fold greater than those in plasma. In addition to
their well-defined role in antibody production, B cells
may also regulate immune responses to microbes and
participate in inflammation through production of cyto-
kines, chemokines, and growth factors [21-24]. Human
B cells have shown to produce cytokines, including* Correspondence: sgupta@uci.edu
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reproduction in any medium, provided the orproinflammatory cytokines IL-6, TNF-α, and immunore-
gulatory and anti-inflammatory cytokines, such TGF-β,
and IL-10 [21-24]. We have recently reported that leptin
activates human B cells to induce secretion of IL-6 and
TNF-α and IL-10, and this effect of leptin on B cells is
mediated via JAK2/STAT3 and p38MAPK/ERK1/2 sig-
naling pathways [25].
In this study, we show that leptin activates B cells and
B cell subsets from aged subjects to a significantly
greater extent, and induces significantly higher levels of
secretion of IL-6, TNF-α, and IL-10 as compared to B
cells and B cell subsets from young subjects. This
appears to be due to an increased leptin-induced phos-
phorylation of STAT-3 in B cells from aged as compared
to young controls.Results
Leptin induces greater activation of B cells from aged as
compared to young humans
Purified B cells were activated with 50 ng/ml of leptin
(optimum concentration-reference# 25) for 24 hours.
Cells were washed and stained with anti-CD19 antibody,
anti-CD5 antibody, and antibodies directed against CD25,
and CD69 as activation markers. Figure 1 shows a repre-
sentative cytofluorograph. In aging, leptin induced (red
line) greater activation (increased expression of CD25 andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and










Figure 1 Effect of leptin on activation of B cells and B cell subsets. Purified B cells from young and aged subjects were stimulated with
leptin (50 ng/ml) for 24 hours and expression of CD25 and CD69 as activation markers, using specific antibodies and isotype controls. Blue lines
are for unactivated B cells, and red line for leptin-activated B cells.
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to young control. Furthermore, increased activation in
aging was observed in both CD5+ and CD5- B cells.
Tables 1 and 2 show data from 10 aged and 10 young sub-
jects. A significantly greater upregulation of both CD25
and CD69 antigens over the baseline levels was observed
on CD19+, and CD5+ and CD5- B cells in aged humans
as compared to B cells and B cell subsets in young
(Table 1). Furthermore, greater upregulation was observed
in CD5+ B cells as compared to CD5- B cells. When data
were analyzed for the density of these molecules as mea-
sured by mean fluorescence intensity (MFI), significant in-
crease in aging was observed for CD25 expression
(Table 2).Table 1 Effect of Leptin on the expression of activation mark
Marker Young
CD19 CD5+
CD25 Control 2.8 ± 0.4 3.5 ± 0.4
Activated 8.3 ± 1.1 4.0 ± −.3
CD69 Control 1.8 ± 0.2 2.4 ± 0.5
Activated 4.3 ± 0.6 2.6 ± 0.3
P value:
CD25, Aging vs. Young: CD19 = P < 0.01, CD5 + = P < 0.001, CD5- = P < 0.05.
CD69, Aging vs. Young: CD19 = P < 0.05, CD5+ = P < 0.01, CD5- = P < 0.05.Leptin-induced production of IL-6, TNF-α, and IL-10 by B
cells from young and aged subjects
Purified B cells were stimulated with 25 ng/ml and
50 ng/ml of leptin for 24 hours and supernatants were
collected and stored at −20°C until assayed for IL-6,
TNF-α, and IL-10 by ELISA. Cytokine secreting B cells
were also analyzed by ELISPOT. Figure 2 show data
from ELISA assay. Leptin at both 25 ng/ml and 50 ng/ml
induced significantly (P < 0.05) greater amounts of IL-6,
TNF-α, and IL-10 by B cells from aged as compared to
young subjects. Similar data were obtained for IL-6,
TNF-α, and IL-10 secreting B cells as determined by
ELISPOT assay (Figure 3). We observed no difference
in these cytokines production between B cells purifieders on B cell subsets (%)
Aged
CD5- CD19 CD5+ CD5-
3.0 ± 0.3 3.5 ± 0.2 5.0 ± 0.7 1.8 ± 0.4
10.0 ± 1.3 26.3 ± 2.8 15.0 ± 2.3 12.0 ± 1.9
1.9 ± 0.5 5.5 ± 1.0 3.1 ± 0.4 2.5 ± 0.3
4.8 ± 0.3 8.2 ± 0.5 7.6 ± 0.8 6.9 ± 0.4
Table 2 Effect of Leptin on the expression of activation markers on B cell subsets (MFI)
Marker Young Aged
CD19 CD5+ CD5- CD19 CD5+ CD5-
CD25 Control 3.6 ± .4 5.6 ± 2 5.6 ± 2 10 ± 4 7 ± 1.25 10 ± 7
Activated 9.6 ± 1.7 9.5 ± 1.4 9.5 ± 1.4 26 ± 2 15 ± 2.5 51 ± 4.6
CD69 Control 4.5 ± 2 8.8 ± 5 4.1 ± 1.6 4.5 ± .4 7 ± 3.5 3.6 ± 8
Activated 7.6 ± 2.6 11 ± 5.9 7.3 ± 1.7 8.6 ± .47 20 ± 5.7 8 ± .8
P value:
CD25, Aging vs. Young: CD19 = P < 0.01, CD5 + = P < 0.001, CD5- = P < 0.045.
CD69, Aging vs. Young: CD19 = ns, CD5+ = P < 0.02, CD5- = ns.
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selection, therefore, excluding any possibility of activa-
tion of B cells during positive selection (data not
shown).
Increased sensitivity of B cells to leptin in aging is due to
increased positive downstream signaling event
Since leptin induces cytokines by activation of down-
stream signaling pathways, including phosphorylation of
STAT3 [25], we examined leptin-induced phosphoryl-
ation of STAT3 in purified B cells from aged and young
subjects. Purified B cells were stimulated with 50 ng/ml
of leptin for 10 min, and phosphorylation of STAT3 was
determined by Western blotting using specific anti-
bodies. Actin was used as a loading internal control.
Quantitative analysis was performed by densitometry.


































Figure 2 Leptin-induced secretion of cytokines. Purified B cells from yo
(25 ng/ml and 50 ng/ml) for 24 hours and supernatants were analyzed for
sd. Each experiment was done in triplicates.of STAT3 in aging B cells as compared to B cells from
young subjects suggesting an increased activation of posi-
tive downstream signaling in aging.
Discussion
In this study we have demonstrated that leptin activates
B cells from aged humans and induces significantly
higher amounts of TNF-α, IL-6, and IL-10 as compared
to B cells from young subjects. This is in part due to an
increased phosphorylation of STAT3.
Aging is considered a state of chronic inflammation.
Plasma levels of proinflammatory cytokines, including
IL-6 and TNF-α are increased in human aging [6-11];
however, the cellular source of increased proinflamma-
tory cytokines is poorly understood. These cytokines are
produced by T cells, macrophages, and B cells. However,
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Figure 3 Leptin-stimulated cytokine secreting B cells. Purified B cells (12,500-50,000/well) from young and aged were cultured in the absence
or presence of leptin (25 ng/ml and 50 ng/ml) for 24 hours and TNF-α, IL-6, and IL-10 secreting B cells were analyzed by ELISPOT assay. Data are
expressed as mean ± sd. Each experiment was done in triplicates.
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fore, B cells is likely one of the sources of increased
proinflammatory cytokines associated with human aging,
though dendritic cells in aging may also contribute to
increased levels of proinflammatory cytokines [26]. Re-

















Figure 4 Leptin-induced phosphorylation of STAT3 in B cells.
Purified B cells from young and aged were cutlured in the presence
and absence of 50 ng/ml leptin for 10 min and native and
phosphorylated STAT3 were analyzed by Western blot using specific
antibodies. Actin was used an an internal loading control.
Quantitation of bands was performed by densitometry and shown
in table below.cytokines, chemokines, and growth factors with proin-
flammatory properties [21-25].
Leptin is one of adipokines, which is powerful inducer
of inflammatory cytokines by Th1 T cells and macro-
phages, including IFN-γ, IL-1β, TNF-α, and IL-6
[1-5,27,28]. More recently, we have reported that leptin
also activates human B cells to induce inflammatory
cytokines, including IL-6 and TNF-α, and anti-inflam-
matory/ immunoregulatory cytokine IL-10 [29-31]. We
have reported that leptin activates human B cells [25],
and serum levels of leptin are increased in aging [17-20].
Since leptin and proinflammatory cytokines are increased
in aging, and T cell-and macrophage-derived proinflam-
matory cytokines are decreased in aging, we investigated
the effects of leptin on purified B cells. In the present
study we show that leptin activates human aged B cells
to a greater extent than B cells from young subjects as
evidenced by upregulation of CD25 and CD69, which
was observed on both CD19 + CD5+ B cells and CD19 +
CD5-B cells, greater upregulation was observed in CD5+
B cells as compared to CD5- B cells. CD5+ B cells are
reported to produce IL-10 with immunoregulatory prop-
erty [32], which may explain a role of leptin in auto-
immunity [1,33].
Activation of B cells was also associated with increased
production of cytokines by B cells. Leptin induced sig-
nificantly higher (P < 0.05) secretion of IL-6, TNF-α, and
IL-10 by B cells (ELISA assay) from aged humans as
compared to B cells from young subjects. Furthermore,
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amounts of secreted cytokines by aged B cells, but lep-
tin also increased significantly higher number B cells
(ELISPOT assay) to secrete these cytokines. Increase in
leptin-induced IL-10 in aging may suggest a compensa-
tory mechanism to counterbalance increased IL-6 and
TNF-α production. Since B regulatory cells produce
IL-10 [34] it is possible that increased IL-10 production
might be due to increased Breg in aging. This possibil-
ity is under investigation. IL-10 rescues CD5+ cells
from apoptosis and augments the proliferation of CD5-
B cells [35-39]. Since IL-6 and TNF-α are produced by
both CD5+ and CD5- B cells, increased leptin-induced
B cell-derived IL-10 in aging may be playing a role in
aging-associated chronic inflammation by surviving B
cells from apoptosis to produce IL-6 and TNF-α. Buffa
et al. [40] have reported an expansion of CD19 + CD38-
CD24- B cells in aged humans and these cells produce
both TNF-α and IL-10.
Leptin signal via three distinct pathways, including
JAK-STAT, PI3K, and MAPK pathways [41-43]. Follow-
ing binding of leptin with leptin receptor, JAK2 (Janus
kinase 2) is activated by auto-or cross phosphorylation.
Activated JAK2 tyrosine phosphorylates intracellular do-
main of leptin receptor. The phosphorylated receptor
provides a docking site for STAT (signal transducer and
activator of transcription) factors, particularly STAT3,
which is substrate of JAK2. STAT3 itself is a substrate
for JAK2 and homo- or hetero-dimerization upon phos-
phorylation, translocates to the nucleus, and modulates
transcription of genes, including cytokine genes. We
show that Leptin induced significantly greater phosphor-
ylation of STAT3 in B cells from aged subjects as com-
pared to B cells from young controls, suggesting that
leptin-induced increased cytokine production by aged B
cells is via increased activation of STAT3.
Conclusions
Leptin activates B cells from aged humans via increased
intracellular signaling to secrete IL-6, TNF-α, and IL-10
to a greater extent than B cells in young subjects, which




Peripheral blood mononuclear cells (MNCs) were isolated
from blood of 10 healthy young (18–35 years, mean 23±4)
and 10 healthy aged (66–84 years, mean 74±6) subjects
by Ficoll–hypaque density gradient. Aged subjects are
healthy people of middle and upper middle social sta-
tus, and are living active independent lives in the city of
Laguna Woods, California (senior community). All sub-
jects were required to discontinue all vitamins andantioxidants (if they were taking) for at least one year
prior to donation of blood sample. Protocol was
approved by Human Subject Committee of the Institu-
tion Review Board of the University of California,
Irvine. Consent form approved by the Institutional Re-
view Board of the University of California was signed
by each subject. Consent form states that publications
and/or presentations that result from this study will not
include identifiable information about you.Antibodies and reagents
The following anti-human immunoglobulins were used:
CD19 PerCP, CD69 FITC, CD25 APC, and CD5 PE; all
from BD Parmingen (San Jose, CA). B cell enrichment kit
was purchased from Stem cell Technologies (Vancouver,
BC, Canada), and recombinant human leptin from
PeproTech (Rocky Hill, New Jersey).Immunophenotyping
B cells were stained with, APC-conjugated anti-CD25,
FITC-conjugated anti-CD69, PE-conjugated anti-CD5
monoclonal antibodies. After staining, cells were washed
extensively with phosphate-buffered saline and analyzed
by Flow cytometry using FACScalibur (Becton-Dickenson,
San Jose, CA) equipped with argon ion laser emitting at
488 nm (for FITC, PE, and PerCP excitation) and a
spatially separate diode laser emitting at 631 nm (for
APC excitation). Forward and side scatters were used
to gate and exclude cellular debris. Ten thousand cells
were acquired and analyzed using Flowjo software
(Treestar, Ashland, OR). Data were analyzed for both
percentages of cells expressing CD25 and CD69 as well
as density of molecules as defined by mean fluoresence
intensity (MFI).Purification of B cells
B lymphocytes were purified by immunomagnetic human
B cell enrichment kit according to manufacturer ’s instruc-
tions (STEMCELL Technologies, Vancouver, Canada). In
brief, peripheral blood mononuclear cells were suspended
at no more than 1 × 108 cells/ml in PBS containing 2%
FBS. Negative selection cocktail (100 μl/ml) was added
and incubated at room temperature for 15 min. The mag-
netic nanoparticles were added at 50 μl/ml cells and incu-
bated for 10 min. Cells were placed in a 12 × 75-mm
polystyrene tube at a volume of 2.5 ml/tube and placed
into the magnet for 5 min. The magnet was inverted, and
the supernatant was poured off. The magnetically labeled
unwanted cells remain bound inside the original tube. The
purity of negatively selected cells was assessed by flow
cytometry (>97%) as detected by the presence of CD20.
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Cytokine secretion was measured by ELISA, and ELISPOT
assays. Purified B cells were activated by 25 ng/ml and
50 ng/ml of leptin for 24 h. Supernatants were collected
and stored at −20°C until assayed for detection of cytokines
by ELISA (ELISA kits from BD Pharmingen, San Jose, CA)
as per manufacturer ’s protocol. Cytokine secreting cells
were measured by ELISPOT assay according to manufac-
turer ’s protocol. In brief, PVDF membrane ELISPOT
plates (Millipore, Billerica, MA) were coated with 100 μl
(conc. 2 μg/ml) of capture antibody per well (BD Pharmin-
gen, San Jose), and were kept overnight at 4°C. Plates were
washed 3 times with sterile PBS and 200 μl/well of sterile
blocking buffer was added for ≥ 1 hour. Plates were washed
3 times with sterile PBS. Purified B cells (12,500; 25,000;
and 50,000/well) were placed in triplicate. Twenty five and
50 ng/ml leptin was added to each well and plates were
incubated at 37°C 5% CO2 incubator for 48 hrs. Plates were
first washed x3 times with PBS, and then 3 times with
PBS-Tween. 100 μl/well of diluted biotinylated detection
antibody (BD Pharmingen, San Jose, California) was
added at 2 μg/ml and incubate for 2 hr at room
temperature. Plates were washed with PBS-Tween, and
100 μl/ well of the Av-HRP conjugate (BD Pharmingen,
San Jose, California) added and incubate at room
temperature for 1 hours. 200 μl/well of fresh substrate so-
lution was added and spot/color development was moni-
tored. Reaction was stopped by rinsing plate with tap
water, and followed by blotting on paper towels. Plates
were allowed to air dry overnight. Spots were counted
manually with a dissecting microscope, and expressed as
spots/50,000 B cells.Western blotting
Purified B cells were incubated in the presence or absence
of 50 ng/ml of leptin for 10 min, and cells were lysed with
lysis buffer. Aliquots of cell lysates containing 20 μg of
total protein were resolved by SDS–PAGE and transferred
onto membranes (Millipore, Bedford, MA) by electroblot-
ting. The membranes were blocked for 1 h at room
temperature in TBS-T buffer with 5% nonfat dried milk
and incubated with primary antibodies overnight at 4°C.
The blots were washed three times for 20 min with TBS-T
buffer and then incubated with HRP-conjugated second-
ary antibodies (1:3,000–1:6,000 dilution) for 1 h at room
temperature. After washing three times for 20 min in
TBS-T buffer, blots were developed using enhanced
chemiluminescence reagents (ECL, Pierce Biotechnology,
Inc., Rockford, IL) and exposed to clear-blue X-Ray film.
Actin was used as a loading control. Bands were scanned,
and volumes were calculated. Quantification was done by
a ratio between STAT-3 or pSTAT-3 and actin.
Statistical analysis was performed by paired student t testCompeting interests
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